United States HR 3839: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Status: Referred to the Subcommittee on Health. (as of 2023-06-09)

State: United States · Session: 118 · Bill: HR 3839

Sponsors: Neal P. Dunn, Ann M. Kuster

View United States HR 3839 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.